Literature DB >> 29042400

Thrombus Aspiration for ST-Segment-Elevation Myocardial Infarction in Modern Era: Still an Issue of Debate?

Junhua Ge1, Andreas Schäfer1, Georg Ertl1, Peter Nordbeck2.   

Abstract

The role of manual thrombus aspiration (TA) during primary percutaneous coronary intervention (PPCI) for acute ST-segment-elevation myocardial infarction has been a matter of intense research and debate now. Although recent randomized controlled clinical trials (notably TASTE [Thrombus Aspiration in ST-Elevation Myocardial Infarction in Scandinavia] and TOTAL [Trial of Routine Aspiration Thrombectomy With PCI Versus PCI Alone in Patients With STEMI]) do not supply evidence supporting the routine use of TA in patients with ST-segment-elevation myocardial infarction, manual TA remains a therapeutic option for interventional cardiologists when treating patients with substantial thrombus burden during PPCI. It remains unknown whether patients might actually benefit from TA applied in a more selective manner depending on the thrombus burden during PPCI, instead of routine application. In this review, we summarize current knowledge on the instruments used in the TA procedure, positive as well as negative clinical effects of TA during PPCI, and analyze the potential reasons for observed effects, in an effort to help the clinical decision making by physicians for the use of TA in individual ST-segment-elevation myocardial infarction patients during PPCI.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  STEMI; clinical decision making; myocardial infarction; percutaneous coronary intervention; thrombectomy

Mesh:

Year:  2017        PMID: 29042400     DOI: 10.1161/CIRCINTERVENTIONS.117.005739

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  12 in total

1.  Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry.

Authors:  Eric A Secemsky; Enrico G Ferro; Sunil V Rao; Ajay Kirtane; Hector Tamez; Pearl Zakroysky; Daniel Wojdyla; Steven M Bradley; David J Cohen; Robert W Yeh
Journal:  JAMA Cardiol       Date:  2019-02-01       Impact factor: 14.676

2.  Advances in Coronary No-Reflow Phenomenon-a Contemporary Review.

Authors:  Ahmadreza Karimianpour; Anbukarasi Maran
Journal:  Curr Atheroscler Rep       Date:  2018-07-05       Impact factor: 5.113

3.  [Platelet inhibition in elderly patients].

Authors:  A Schäfer; J Bauersachs
Journal:  Herz       Date:  2018-05       Impact factor: 1.443

4.  Alprostadil Injection Attenuates Coronary Microembolization-Induced Myocardial Injury Through GSK-3β/Nrf2/HO-1 Signaling-Mediated Apoptosis Inhibition.

Authors:  Zhenbai Qin; Binghui Kong; Jing Zheng; Xiantao Wang; Lang Li
Journal:  Drug Des Devel Ther       Date:  2020-10-22       Impact factor: 4.162

5.  Thrombus aspiration during primary percutaneous coronary intervention improved outcome in patients with STEMI and a large thrombus burden.

Authors:  Ning Bin; Feifei Zhang; Xuelian Song; Yuetao Xie; Meixue Jia; Yi Dang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

6.  A new technique to salvage myocardium following the failure of thrombus aspiration in acute myocardial infarction: a case report.

Authors:  Daoyuan Si; Guohui Liu; Yaliang Tong; Cheng Zhang; Yuquan He
Journal:  BMC Cardiovasc Disord       Date:  2018-12-10       Impact factor: 2.298

Review 7.  Lifetime cardiovascular management of patients with previous Kawasaki disease.

Authors:  Paul Brogan; Jane C Burns; Jacqueline Cornish; Vinod Diwakar; Despina Eleftheriou; John B Gordon; Huon Hamilton Gray; Thomas William Johnson; Michael Levin; Iqbal Malik; Philip MacCarthy; Rachael McCormack; Owen Miller; Robert M R Tulloh
Journal:  Heart       Date:  2019-12-16       Impact factor: 5.994

8.  Micro-CT-Based Quantification of Extracted Thrombus Burden Characteristics and Association With Angiographic Outcomes in Patients With ST-Elevation Myocardial Infarction: The QUEST-STEMI Study.

Authors:  Efstratios Karagiannidis; Andreas S Papazoglou; Georgios Sofidis; Evangelia Chatzinikolaou; Kleoniki Keklikoglou; Eleftherios Panteris; Anastasios Kartas; Nikolaos Stalikas; Thomas Zegkos; Fotios Girtovitis; Dimitrios V Moysidis; Leandros Stefanopoulos; Kleanthis Koupidis; Stavros Hadjimiltiades; George Giannakoulas; Christos Arvanitidis; James S Michaelson; Haralambos Karvounis; Georgios Sianos
Journal:  Front Cardiovasc Med       Date:  2021-04-21

9.  China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial.

Authors:  Yi Xu; Xiangdong Li; Haitao Zhang; Yuan Wu; Jun Zhang; Jia Li; Kefei Dou; Hongbing Yan; Shijie You; Yanmin Yang; Yan Liang; Lianjun Xu; Xiaojin Gao; Chen Liu; Qiuting Dong; Wenjia Zhang; Guangyuan Song; Tao Zhang; Lin Jiang; Guihao Chen; Ruijie Tang; Chen Jin; Jingang Yang; Chen Yao; Ying Xian; Eric D Peterson; Runlin Gao; Yuejin Yang
Journal:  Am Heart J       Date:  2020-06-20       Impact factor: 4.749

10.  SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.

Authors:  Raffaele Marfella; Pasquale Paolisso; Celestino Sardu; Luciana Palomba; Nunzia D'Onofrio; Arturo Cesaro; Michelangela Barbieri; Maria Rosaria Rizzo; Ferdinando Carlo Sasso; Lucia Scisciola; Fabrizio Turriziani; Massimiliano Galdiero; Danilo Pignataro; Fabio Minicucci; Maria Consiglia Trotta; Michele D'Amico; Ciro Mauro; Paolo Calabrò; Maria Luisa Balestrieri; Giuseppe Signioriello; Emanuele Barbato; Marilena Galdiero; Giuseppe Paolisso
Journal:  Crit Care       Date:  2021-06-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.